Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Medtronic
Baxter
Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Fruquintinib


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Fruquintinib?

Fruquintinib is an investigational drug.

There have been 42 clinical trials for Fruquintinib. The most recent clinical trial was a Phase 3 trial, which was initiated on April 20th 2019.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, and Adenocarcinoma. The leading clinical trial sponsors are Hutchison Medipharma Limited, Fudan University, and The First Affiliated Hospital with Nanjing Medical University.

There are twenty-one US patents protecting this investigational drug and two hundred and thirty international patents.

Recent Clinical Trials for Fruquintinib
TitleSponsorPhase
Fruquintinib in the Treatment of Soft Tissue SarcomaFudan UniversityPhase 2
Phase II Study of Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric AdenocarcinomaGuangxi Medical UniversityPhase 2
Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRCSun Yat-sen UniversityPhase 2

See all Fruquintinib clinical trials

Clinical Trial Summary for Fruquintinib

Top disease conditions for Fruquintinib
Top clinical trial sponsors for Fruquintinib

See all Fruquintinib clinical trials

US Patents for Fruquintinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fruquintinib ⤷  Try it Free .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA) ⤷  Try it Free
Fruquintinib ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Fruquintinib ⤷  Try it Free Piperazine derivatives as liver X receptor modulators Vitae Pharmaceuticals, Inc. (Madison, NJ) ⤷  Try it Free
Fruquintinib ⤷  Try it Free Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof QUADRIGA BIOSCIENCES, INC. (Los Altos, CA) ⤷  Try it Free
Fruquintinib ⤷  Try it Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
Fruquintinib ⤷  Try it Free Modulators of chemokine receptors ChemoCentryx, Inc. (Mountain View, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fruquintinib

Drugname Country Document Number Estimated Expiration Related US Patent
Fruquintinib Argentina AR105592 2035-08-03 ⤷  Try it Free
Fruquintinib Australia AU2016302243 2035-08-03 ⤷  Try it Free
Fruquintinib Canada CA2994404 2035-08-03 ⤷  Try it Free
Fruquintinib China CN108026026 2035-08-03 ⤷  Try it Free
Fruquintinib European Patent Office EP3331851 2035-08-03 ⤷  Try it Free
Fruquintinib Hong Kong HK1247608 2035-08-03 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Medtronic
Baxter
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.